Frontal pole-precuneus connectivity is associated with a discrepancy between self-rated and observer-rated depression severity in mood disorders: a resting-state functional magnetic resonance imaging study.
Shintaro KawakamiNaohiro OkadaYoshihiro SatomuraEimu ShojiShunsuke MoriMasahiro KiyotaFavour OmilekeYu HamamotoSusumu MoritaDaisuke KoshiyamaMika YamagishiEisuke SakakibaraShinsuke KoikeKiyoto KasaiPublished in: Cerebral cortex (New York, N.Y. : 1991) (2024)
Discrepancies in self-rated and observer-rated depression severity may underlie the basis for biological heterogeneity in depressive disorders and be an important predictor of outcomes and indicators to optimize intervention strategies. However, the neural mechanisms underlying this discrepancy have been understudied. This study aimed to examine the brain networks that represent the neural basis of the discrepancy between self-rated and observer-rated depression severity using resting-state functional MRI. To examine the discrepancy between self-rated and observer-rated depression severity, self- and observer-ratings discrepancy (SOD) was defined, and the higher and lower SOD groups were selected from depressed patients as participants showing extreme deviation. Resting-state functional MRI analysis was performed to examine regions with significant differences in functional connectivity in the two groups. The results showed that, in the higher SOD group compared to the lower SOD group, there was increased functional connectivity between the frontal pole and precuneus, both of which are subregions of the default mode network that have been reported to be associated with ruminative and self-referential thinking. These results provide insight into the association of brain circuitry with discrepancies between self- and observer-rated depression severity and may lead to more treatment-oriented diagnostic reclassification in the future.
Keyphrases
- resting state
- functional connectivity
- magnetic resonance imaging
- depressive symptoms
- sleep quality
- randomized controlled trial
- contrast enhanced
- amyotrophic lateral sclerosis
- end stage renal disease
- bipolar disorder
- newly diagnosed
- magnetic resonance
- peritoneal dialysis
- computed tomography
- prognostic factors
- single cell
- skeletal muscle
- brain injury
- patient reported outcomes
- smoking cessation
- multiple sclerosis
- glycemic control